As of the end of May 2023, Medicilon has successfully assisted in the clinical approval of 7 GLP-1 drugs (3 approved by FDA and NMPA1 approved by FDA, NMPA, and TGA) and has multiple GLP-1 projects under development
Based on clinical trial results, some individuals may see an improvement in glucose control as measured by A1c within the first 4 weeks, which can correlate with weight loss, but individual results can vary
This USP-referenced preparation standard is manufactured under strictly controlled handling conditions
If you can access it through insurance, a savings program, or affordable compounding options , tirzepatide is the more effective choice for most patients seeking significant weight loss
This is a high bar
The effect is gradual and cumulative